3020 Children's Way
San Diego, CA 92123
Rady Children's Specialists of San Diego
Rady Children's Specialists
Duke University School of Medicine
Duke University School of Medicine
Duke University School of Medicine
University of Michigan Health Systems
Pediatric Hematology/Oncology, Pediatrics
Dr. Courtney Thornburg is the medical director of the Hemophilia and Thrombosis Treatment Center at Rady Children's Hospital-San Diego and the co-director of the Hemostasis and Thrombosis Research Program. She is also an associate professor of clinical pediatrics at UC San Diego School of Medicine.
Dr. Thornburg graduated from Duke University Medical School, completed her pediatric residency at Duke University Medical Center, and completed her pediatric hematology/oncology fellowship at the University of Michigan, where she also earned a master's degree in clinical research design and statistical analysis. During her time in Michigan she focused her training on hemophilia and other bleeding disorders. From 2005-2013, Dr. Thornburg was on the faculty at Duke University, where she directed the sickle cell and hemostasis and thrombosis programs.
Dr. Thornburg is committed to taking care of children with blood disorders, including bleeding disorders, clotting disorders and inherited red blood cell disorders. She conducts clinical research to improve the care of children with blood disorders and is currently an investigator for multiple clinical studies at Rady Children's. To help educate the next generation of physicians, Dr. Thornburg teaches medical students, residents and fellows.
Dr. Thornburg is a member of the American Society of Pediatric Hematology/Oncology, the American Society of Hematology, the International Society of Haemostasis and Thrombosis and the Hemophilia and Thrombosis Research Society. At Rady Children's, she is the lead physician for the Venous Thromboembolism Prevention Task Force.
In addition to her career in medicine, Dr. Thornburg enjoys spending time with her family, traveling and playing tennis.
Ataxia telangiectasia presenting as hyper IgM syndrome without neurologic signs.
Doshi A, Ryu J, Thornburg CD, Hershey D, Cherry R, Milligan K, Rosenzweig S, Leonard S
Initial Evaluation of the Pediatric PROMISÂ® Health Domains in Children and Adolescents With Sickle Cell Disease.
Dampier C, Barry V, Gross HE, Lui Y, Thornburg CD, DeWalt DA, Reeve BB
Effects of hydroxyurea treatment for patients with hemoglobin SC disease.
Luchtman-Jones L, Pressel S, Hilliard L, Brown RC, Smith MG, Thompson AA, Lee MT, Rothman J, Rogers ZR, Owen W, Imran H, Thornburg C, Kwiatkowski JL, Aygun B, Nelson S, Roberts C, Gauger C, Piccone C, Kalfa T, Alvarez O, Hassell K, Davis BR, Ware RE
Hematologic outcomes after total splenectomy and partial splenectomy for congenital hemolytic anemia.
Englum BR, Rothman J, Leonard S, Reiter A, Thornburg C, Brindle M, Wright N, Heeney MM, Jason Smithers C, Brown RL, Kalfa T, Langer JC, Cada M, Oldham KT, Scott JP, St Peter SD, Sharma M, Davidoff AM, Nottage K, Bernabe K, Wilson DB, Dutta S, Glader B, Crary SE, Dassinger MS, Dunbar L, Islam S, Kumar M, Rescorla F, Bruch S, Campbell A, Austin M, Sidonio R, Blakely ML, Rice HE, Splenectomy in Congenital Hemolytic Anemia Consortium.
Fatigue in Children With Sickle Cell Disease: Association With Neurocognitive and Social-Emotional Functioning and Quality of Life.
Anderson LM, Allen TM, Thornburg CD, Bonner MJ
Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia.
Estepp JH, Melloni C, Thornburg CD, Wiczling P, Rogers Z, Rothman JA, Green NS, Liem R, Brandow AM, Crary SE, Howard TH, Morris MH, Lewandowski A, Garg U, Jusko WJ, Neville KA, Best Pharmaceuticals for Children Act-Pediatric Trials Network Administrative Core Committee.
From infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemia.
Hankins JS, Aygun B, Nottage K, Thornburg C, Smeltzer MP, Ware RE, Wang WC
Clinical outcomes of splenectomy in children: report of the splenectomy in congenital hemolytic anemia registry.
Rice HE, Englum BR, Rothman J, Leonard S, Reiter A, Thornburg C, Brindle M, Wright N, Heeney MM, Smithers C, Brown RL, Kalfa T, Langer JC, Cada M, Oldham KT, Scott JP, St Peter S, Sharma M, Davidoff AM, Nottage K, Bernabe K, Wilson DB, Dutta S, Glader B, Crary SE, Dassinger MS, Dunbar L, Islam S, Kumar M, Rescorla F, Bruch S, Campbell A, Austin M, Sidonio R, Blakely ML, Splenectomy in Congenital Hemolytic Anemia (SICHA) Consortium.
Congenital hemophagocytic lymphohistiocytosis presenting as thrombocytopenia in a newborn.
Hinson A, Owen W, Prose N, Parikh S, Thornburg C
Hospital-acquired venous thromboembolism in children: call-to-action.
Mahajerin A, Thornburg CD
Travelers with sickle cell disease.
Willen SM, Thornburg CD, Lantos PM
Do difficulties in swallowing medication impede the use of hydroxyurea in children?
Bekele E, Thornburg CD, Brandow AM, Sharma M, Smaldone AM, Jin Z, Green NS
A 2-year-old girl with co-inherited cystic fibrosis and sickle cell-Î²+ thalassemia presenting with recurrent vaso-occlusive events during cystic fibrosis pulmonary exacerbations: a case report.
Sobush KT, Thornburg CD, Voynow JA, Davis SD, Peterson-Carmichael SL
Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association.
Desch KC, Ozel AB, Siemieniak D, Kalish Y, Shavit JA, Thornburg CD, Sharathkumar AA, McHugh CP, Laurie CC, Crenshaw A, Mirel DB, Kim Y, Cropp CD, Molloy AM, Kirke PN, Bailey-Wilson JE, Wilson AF, Mills JL, Scott JM, Brody LC, Li JZ, Ginsburg D
Report of a young girl with MYH9 mutation and review of the literature.
Landi D, Lockhart E, Miller SE, Datto M, Rehder C, Kanaly A, Thornburg CD
Trends in venous thromboembolism-related hospitalizations, 1994-2009.
Boulet SL, Grosse SD, Thornburg CD, Yusuf H, Tsai J, Hooper WC
Characterization of the hypercoagulable state in patients with sickle cell disease.
Shah N, Thornburg C, Telen MJ, Ortel TL
Impact of hydroxyurea on clinical events in the BABY HUG trial.
Thornburg CD, Files BA, Luo Z, Miller ST, Kalpatthi R, Iyer R, Seaman P, Lebensburger J, Alvarez O, Thompson B, Ware RE, Wang WC, BABY HUG Investigators.
Translocation of sickle cell erythrocyte microRNAs into Plasmodium falciparum inhibits parasite translation and contributes to malaria resistance.
LaMonte G, Philip N, Reardon J, Lacsina JR, Majoros W, Chapman L, Thornburg CD, Telen MJ, Ohler U, Nicchitta CV, Haystead T, Chi JT
Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia.
Josephson CD, Granger S, Assmann SF, Castillejo MI, Strauss RG, Slichter SJ, Steiner ME, Journeycake JM, Thornburg CD, Bussel J, Grabowski EF, Neufeld EJ, Savage W, Sloan SR
Effect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia.
Alvarez O, Miller ST, Wang WC, Luo Z, McCarville MB, Schwartz GJ, Thompson B, Howard T, Iyer RV, Rana SR, Rogers ZR, Sarnaik SA, Thornburg CD, Ware RE, BABY HUG Investigators.
Severe fetal and neonatal hemolytic anemia due to a 198 kb deletion removing the complete Î²-globin gene cluster.
Verhovsek M, Shah NR, Wilcox I, Koenig SC, Barros T, Thornburg CD, Steinberg MH, Luo HY, Chui DH
Evaluation of partial and total splenectomy in children with sickle cell disease using an Internet-based registry.
Mouttalib S, Rice HE, Snyder D, Levens JS, Reiter A, Soler P, Rothman JA, Thornburg CD
Complications of implantable venous access devices in patients with sickle cell disease.
Shah N, Landi D, Shah R, Rothman J, De Castro LM, Thornburg CD
See the full listing of this physician's publications on PubMed, a service of the National Library of Medicine.
PubMed is a third-party website and not affiliated with Rady Children's Hospital-San Diego.